- 現金殖利率: 4.12%、總殖利率: 4.12%、5年平均現金配發率: 94.0%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 4.18 | 66.53 | 4.00 | 75.44 | 0.00 | 0 | 95.69 | 5.35 | 0.00 | 0 | 95.69 | 5.35 |
| 2022 (9) | 2.51 | 578.38 | 2.28 | 0 | 0.00 | 0 | 90.84 | 0 | 0.00 | 0 | 90.84 | 0 |
| 2021 (8) | 0.37 | -65.74 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | 1.08 | 0.93 | 0.84 | 2.44 | 0.00 | 0 | 77.78 | 1.49 | 0.00 | 0 | 77.78 | 1.49 |
| 2019 (6) | 1.07 | -30.97 | 0.82 | -59.0 | 0.00 | 0 | 76.64 | -40.61 | 0.00 | 0 | 76.64 | -40.61 |
| 2018 (5) | 1.55 | -11.43 | 2.00 | 58.73 | 0.00 | 0 | 129.03 | 79.21 | 0.00 | 0 | 129.03 | 79.21 |
| 2017 (4) | 1.75 | -14.63 | 1.26 | -9.35 | 0.00 | 0 | 72.00 | 6.19 | 0.00 | 0 | 72.00 | 6.19 |
| 2016 (3) | 2.05 | -8.07 | 1.39 | -13.13 | 0.00 | 0 | 67.80 | -5.5 | 0.00 | 0 | 67.80 | -5.5 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 1.44 | 35.85 | 10.77 | 1.24 | 7.83 | 3.33 | 3.48 | 70.59 | 10.83 |
| 24Q2 (19) | 1.06 | 8.16 | 9.28 | 1.15 | 18.56 | 22.34 | 2.04 | 108.16 | 12.09 |
| 24Q1 (18) | 0.98 | -30.99 | 15.29 | 0.97 | -27.07 | 7.78 | 0.98 | -78.22 | 15.29 |
| 23Q4 (17) | 1.42 | 9.23 | 35.24 | 1.33 | 10.83 | 22.02 | 4.50 | 43.31 | 58.45 |
| 23Q3 (16) | 1.30 | 34.02 | 28.71 | 1.20 | 27.66 | 130.77 | 3.14 | 72.53 | 76.4 |
| 23Q2 (15) | 0.97 | 14.12 | 203.12 | 0.94 | 4.44 | 54.1 | 1.82 | 114.12 | 136.36 |
| 23Q1 (14) | 0.85 | -19.05 | 84.78 | 0.90 | -17.43 | 83.67 | 0.85 | -70.07 | 84.78 |
| 22Q4 (13) | 1.05 | 3.96 | 144.19 | 1.09 | 109.62 | 67.69 | 2.84 | 59.55 | 667.57 |
| 22Q3 (12) | 1.01 | 215.62 | 1920.0 | 0.52 | -14.75 | 73.33 | 1.78 | 131.17 | 3066.67 |
| 22Q2 (11) | 0.32 | -30.43 | 900.0 | 0.61 | 24.49 | 154.17 | 0.77 | 67.39 | 800.0 |
| 22Q1 (10) | 0.46 | 6.98 | 757.14 | 0.49 | -24.62 | 96.0 | 0.46 | 24.32 | 757.14 |
| 21Q4 (9) | 0.43 | 760.0 | -37.68 | 0.65 | 116.67 | 1.56 | 0.37 | 716.67 | -70.16 |
| 21Q3 (8) | 0.05 | 225.0 | -89.8 | 0.30 | 25.0 | -26.83 | -0.06 | 45.45 | -115.79 |
| 21Q2 (7) | -0.04 | 42.86 | -119.05 | 0.24 | -4.0 | 500.0 | -0.11 | -57.14 | 0 |
| 21Q1 (6) | -0.07 | -110.14 | 58.82 | 0.25 | -60.94 | 308.33 | -0.07 | -105.65 | 58.82 |
| 20Q4 (5) | 0.69 | 40.82 | 430.77 | 0.64 | 56.1 | 1166.67 | 1.24 | 226.32 | 18.1 |
| 20Q3 (4) | 0.49 | 133.33 | 0.0 | 0.41 | 783.33 | 0.0 | 0.38 | 0 | 0.0 |
| 20Q2 (3) | 0.21 | 223.53 | 0.0 | -0.06 | 50.0 | 0.0 | 0.00 | 100.0 | 0.0 |
| 20Q1 (2) | -0.17 | -230.77 | 0.0 | -0.12 | -100.0 | 0.0 | -0.17 | -116.19 | 0.0 |
| 19Q4 (1) | 0.13 | 0.0 | 0.0 | -0.06 | 0.0 | 0.0 | 1.05 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 4.6 | 17.77 | 13.13 | 37.98 | 18.57 | 11.75 | N/A | - | ||
| 2024/9 | 3.91 | 20.88 | 24.96 | 33.37 | 19.36 | 11.31 | 1.7 | - | ||
| 2024/8 | 3.23 | -22.36 | 4.63 | 29.46 | 18.66 | 11.09 | 1.74 | - | ||
| 2024/7 | 4.16 | 12.7 | 33.22 | 26.23 | 20.65 | 11.8 | 1.63 | - | ||
| 2024/6 | 3.7 | -6.19 | 15.16 | 22.07 | 18.54 | 11.41 | 1.67 | - | ||
| 2024/5 | 3.94 | 4.41 | 24.99 | 18.37 | 19.24 | 11.69 | 1.63 | - | ||
| 2024/4 | 3.77 | -5.06 | 26.9 | 14.43 | 17.76 | 10.71 | 1.78 | - | ||
| 2024/3 | 3.97 | 34.02 | 5.35 | 10.66 | 14.84 | 10.66 | 1.72 | - | ||
| 2024/2 | 2.96 | -20.29 | 2.84 | 6.68 | 21.34 | 10.15 | 1.8 | - | ||
| 2024/1 | 3.72 | 7.34 | 41.64 | 3.72 | 41.64 | 10.99 | 1.66 | - | ||
| 2023/12 | 3.47 | -8.97 | 20.74 | 39.3 | 24.02 | 11.34 | 1.49 | - | ||
| 2023/11 | 3.81 | -6.42 | 16.11 | 35.83 | 24.34 | 11.0 | 1.54 | - | ||
| 2023/10 | 4.07 | 30.08 | 31.05 | 32.03 | 25.4 | 10.29 | 1.64 | - | ||
| 2023/9 | 3.13 | 1.22 | 1.21 | 27.96 | 24.62 | 9.34 | 1.74 | - | ||
| 2023/8 | 3.09 | -1.15 | 36.17 | 24.83 | 28.36 | 9.42 | 1.73 | - | ||
| 2023/7 | 3.13 | -2.57 | 50.01 | 21.74 | 27.32 | 9.49 | 1.72 | 主要係本月美國、日本及歐洲區域營收較去年同期增加。 | ||
| 2023/6 | 3.21 | 1.8 | 12.03 | 18.61 | 24.17 | 9.33 | 1.58 | - | ||
| 2023/5 | 3.15 | 6.0 | 34.68 | 15.41 | 27.04 | 9.9 | 1.49 | - | ||
| 2023/4 | 2.97 | -21.18 | 24.45 | 12.25 | 25.21 | 9.63 | 1.53 | - | ||
| 2023/3 | 3.77 | 30.83 | 29.22 | 9.28 | 25.46 | 9.28 | 1.46 | - | ||
| 2023/2 | 2.88 | 9.77 | 30.64 | 5.51 | 23.0 | 8.38 | 1.62 | - | ||
| 2023/1 | 2.63 | -8.5 | 15.59 | 2.63 | 15.59 | 8.78 | 1.54 | - | ||
| 2022/12 | 2.87 | -12.46 | 27.05 | 31.69 | 23.25 | 9.25 | 1.41 | - | ||
| 2022/11 | 3.28 | 5.61 | 32.92 | 28.82 | 22.88 | 9.47 | 1.37 | - | ||
| 2022/10 | 3.1 | 0.46 | 20.63 | 25.54 | 21.7 | 8.46 | 1.54 | - | ||
| 2022/9 | 3.09 | 36.17 | 42.4 | 22.43 | 21.85 | 7.44 | 1.68 | - | ||
| 2022/8 | 2.27 | 8.89 | 18.86 | 19.34 | 19.11 | 7.22 | 1.73 | - | ||
| 2022/7 | 2.08 | -27.23 | -1.14 | 17.07 | 19.14 | 7.29 | 1.71 | - | ||
| 2022/6 | 2.86 | 22.39 | 79.36 | 14.99 | 22.64 | 7.59 | 1.55 | 主要是去年110年6月疫情嚴重，今年111年各國疫情趨緩，故各區營收皆較去年同期增加，其中以中南美洲.歐洲及國內增加為主要。 | ||
| 2022/5 | 2.34 | -2.04 | 16.17 | 12.13 | 14.12 | 7.65 | 1.54 | - | ||
| 2022/4 | 2.39 | -18.16 | 1.78 | 9.79 | 13.64 | 7.51 | 1.56 | - | ||
| 2022/3 | 2.92 | 32.28 | 9.28 | 7.4 | 18.08 | 7.4 | 1.56 | - | ||
| 2022/2 | 2.21 | -2.87 | 38.48 | 4.48 | 24.61 | 6.74 | 1.71 | - | ||
| 2022/1 | 2.27 | 0.57 | 13.56 | 2.27 | 13.56 | 7.0 | 1.65 | - | ||
| 2021/12 | 2.26 | -8.42 | -7.33 | 25.71 | 9.76 | 7.3 | 1.51 | - | ||
| 2021/11 | 2.47 | -4.15 | 11.72 | 23.45 | 11.74 | 7.21 | 1.53 | - | ||
| 2021/10 | 2.57 | 18.59 | 20.25 | 20.98 | 11.75 | 6.65 | 1.66 | - | ||
| 2021/9 | 2.17 | 13.66 | 3.26 | 18.41 | 10.65 | 6.19 | 1.88 | - | ||
| 2021/8 | 1.91 | -9.43 | -8.79 | 16.24 | 11.72 | 5.61 | 2.07 | - | ||
| 2021/7 | 2.11 | 32.02 | -8.51 | 14.33 | 15.17 | 5.72 | 2.03 | - | ||
| 2021/6 | 1.6 | -20.72 | -16.87 | 12.22 | 20.56 | 5.96 | 1.94 | - | ||
| 2021/5 | 2.01 | -14.17 | 10.38 | 10.63 | 29.31 | 7.03 | 1.64 | - | ||
| 2021/4 | 2.35 | -12.12 | 102.21 | 8.61 | 34.71 | 6.61 | 1.75 | 係因去年台灣內銷市場、美國及歐洲子公司受COVID-19影響，致使109年4月較110年4月營收減少102.22% | ||
| 2021/3 | 2.67 | 67.61 | 53.54 | 6.26 | 19.74 | 6.26 | 1.82 | 係因去年台灣內銷市場、美國及歐洲子公司受COVID-19影響，致使109年3月較110年3月營收減少53.55% | ||
| 2021/2 | 1.59 | -20.34 | -20.32 | 3.59 | 2.9 | 6.03 | 1.89 | - | ||
| 2021/1 | 2.0 | -17.93 | 34.04 | 2.0 | 34.04 | 6.65 | 1.72 | - | ||
| 2020/12 | 2.44 | 10.41 | 10.0 | 23.42 | -3.87 | 6.79 | 1.66 | - | ||
| 2020/11 | 2.21 | 3.15 | 5.71 | 20.98 | -5.26 | 6.45 | 1.75 | - | ||
| 2020/10 | 2.14 | 1.84 | -0.66 | 18.78 | -6.4 | 6.33 | 1.78 | - | ||
| 2020/9 | 2.1 | 0.38 | 2.15 | 16.64 | -7.1 | 6.5 | 1.72 | - | ||
| 2020/8 | 2.09 | -9.15 | 27.2 | 14.54 | -8.3 | 6.32 | 1.77 | - | ||
| 2020/7 | 2.3 | 19.95 | 9.47 | 12.44 | -12.41 | 6.05 | 1.84 | - | ||
| 2020/6 | 1.92 | 5.27 | 10.27 | 10.14 | -16.22 | 4.91 | 2.32 | - | ||
| 2020/5 | 1.82 | 57.21 | -19.77 | 8.22 | -20.67 | 4.72 | 2.41 | - | ||
| 2020/4 | 1.16 | -33.27 | -52.55 | 6.39 | -20.92 | 4.9 | 2.32 | 因國內內銷、美國子公司及法國子公司受到新型冠狀病毒(COVID-19)影響，致使單月收入減少52.55%。 | ||
| 2020/3 | 1.74 | -13.02 | -10.33 | 5.23 | -7.21 | 5.23 | 2.24 | - | ||
| 2020/2 | 2.0 | 34.01 | 21.32 | 3.49 | -5.57 | 5.71 | 2.05 | - | ||
| 2020/1 | 1.49 | -32.65 | -27.2 | 1.49 | -27.2 | 5.8 | 2.02 | - | ||
| 2019/12 | 2.22 | 6.1 | 13.09 | 24.37 | 4.47 | 0.0 | N/A | - | ||
| 2019/11 | 2.09 | -3.06 | 2.15 | 22.15 | 3.68 | 0.0 | N/A | - |
